McKesson (MCK) β†’ Stock, financial statements
Advertising

McKesson

539.26 USD +1.97 (+0.88%)
Mar 27 πŸ‡ΊπŸ‡Έ NYSE MCK
Dividends News
Favorites
  • MCK Ticker
  • πŸ‡ΊπŸ‡Έ NYSE Exchange
  • 78,000 Employees
2 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements β€” McKesson

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
21 ← 16 2021 2020 2019 2018 2017 2016
Total Revenue
240B 230B 210B 210B 200B 190B
Cost Of Revenue
230B 220B 200B 200B 190B 180B
Gross Profit
12B 12B 12B 11B 11B 11B
Research and Development
0 96M 71M 130M 340M 390M
Selling General and Admin
8.8B 9.2B 8.4B 8.1B 7.5B 7.3B
Operating Expense
230B 230B 210B 210B 200B 190B
Operating Income
3.3B 1.7B 3.1B 2.7B 3.5B 3.7B
Other Income Expense Net
0 0 0 0 0 0
EBIT
3.3B 1.7B 3.1B 2.7B 3.5B 3.8B
Interest Income
210M 200M 230M 240M 280M 340M
Pretax Income
-5B 1.1B 610M 240M 6.9B 3.3B
Income Tax
-700M 18M 360M -53M 1.6B 910M
Minority Interest
200M 220M 220M 230M 83M 52M
Net Income
-4.5B 900M 34M 67M 5.1B 2.3B
Net Income Basic
-4.5B 900M 34M 67M 5.1B 2.3B
21 ← 16 2021 2020 2019 2018 2017 2016
Current cash
6.3B 4B 3B 2.7B 2.8B 4B
Short term investments
670M 620M 530M 440M 670M 1.1B
Receivables
19B 20B 18B 18B 18B 18B
Inventory
19B 17B 17B 16B 15B 15B
Other current assets
670M 620M 530M 440M 670M 1.1B
Current assets
45B 42B 38B 37B 37B 38B
Long term investments
20B 19B 21B 23B 24B 18B
Property plant equipment
2.6B 2.4B 2.5B 2.5B 2.3B 2.3B
Goodwill
9.5B 9.4B 9.4B 11B 11B 9.8B
Intangible assets
2.9B 3.2B 3.7B 4.1B 3.7B 3B
Other assets
2.3B 2.3B 2.1B 2B 3.4B 3B
Total assets
65B 61B 60B 60B 61B 57B
Accounts payable
0 0 0 0 0 0
Current long term debt
740M 1.1B 330M 1.1B 1.2B 1.6B
Other current liabilities
43B 42B 37B 36B 34B 33B
Total current liabilities
44B 43B 38B 37B 36B 35B
Long term debt
6.4B 6.3B 7.3B 6.8B 7.3B 6.5B
Other liabilities
9.8B 1.7B 2.1B 2.6B 1.8B 1.8B
Minority Interest
1.5B 1.6B 1.6B 1.7B 1.5B 1.5B
Total Liabilities
65B 56B 52B 51B 50B 48B
Common stock
160M 180M 200M 210M 220M 230M
Retained earning
8.2B 13B 12B 13B 13B 8.4B
Treasury stock
-14B -13B -8.9B -7.7B -6B -3.7B
Capital surplus
β€’ β€’ β€’ β€’ β€’ β€’
Shareholder equity
-21M 5.1B 8.1B 9.8B 11B 8.9B
Net tangible assets
-12B -7.4B -5B -5.2B -3.2B -3.9B
21 ← 16 2021 2020 2019 2018 2017 2016
Net Income
-4.5B 900M 34M 67M 5.1B 2.3B
Depreciation
890M 920M 950M 950M 910M 890M
Changes in receivables
-770M 1.7B 540M -500M 240M 2.1B
Changes in inventories
2.5B 25M 400M 1B -57M 1B
Cash change
2.3B 1B 310M -110M -1.3B -1.3B
Cash flow
4.5B 4.4B 4B 4.3B 4.7B 3.7B
Capital expenditures
-640M -510M -560M -580M -560M -680M
Investments
β€’ β€’ β€’ β€’ β€’ β€’
Investing activity other
β€’ β€’ β€’ β€’ β€’ β€’
Total investing cash flows
-420M -580M -1.4B -1.5B -3.8B -1.6B
Dividends paid
β€’ β€’ β€’ β€’ β€’ β€’
Net borrowings
210M 2.8B 4.1B 4.8B 5.1B 3B
Other financing cash flows
β€’ β€’ β€’ β€’ β€’ β€’
Cash flow financing
-1.7B -2.7B -2.2B -3.1B -2.1B -3.5B
Exchange rate effect
β€’ β€’ β€’ β€’ β€’ β€’

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.